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E-mail address: pauli.ojala@bts.redcross.ﬁ (P.J. OjaOver half of the DNA ofmammalian genomes is transcribed, and one of the emerging enigmas in the ﬁeld of
RNA research is intergenic splicing or transcription induced chimerism. We argue that fused low-copy-
number transcripts constituteneglectedpathologicalmechanismakin to copynumber variation, due to loss
of stoichiometric subunit ratios inprotein complexes. Anobstacle for transcriptomicsmeta-analysis of pub-
lished microarrays is the traditional nomenclature of merged transcript neighbors under same accession
codes. Tandem transcripts cover 4–20% of genomes but are only loosely overlapping in population. They
weremost enriched in systemsmedicine annotations concerning neurology, thalassemia and genital disor-
ders in the GeneGo Inc. MetaCore-MetaDrugTM knowledgebase, evaluated with external randomizations
here. Clinical transcriptomics is good news since new disease etiologies offer new remedies. We identiﬁed
homeotic HOX-transfactors centered around BMI-1, the Grb2 adaptor network, the kallikrein system, and
thalassemia RNA surveillance as vulnerable hotspot chimeras. As a cure, RNA interference would require
veriﬁcation of chimerism from symptomatic tissue contra healthy control tissue from the same patient.
 2008 Elsevier Inc. All rights reserved.1. Introduction
In the endeavor towards developing standard gene nomencla-
ture, the upheaval of the ‘‘RNA-world” literature confounds unam-
biguous data retrieval. Recently, data regarding intergenic splicing
or transcription induced chimerism (TIC) in the human genome
has been published [1–4]. Pioneering studies on the analogous con-
troversial fused transcripts were reported in the mouse [5] and hu-
man, from chromosomes 21 and 22 [6], which revealed that over
half of the DNA of mammalian genome is transcribed, although less
than 4% is translated. There are two types of RNA splicing: cis- and
trans-splicing. Molten gene pairs analyzed in this study result from
cis-splicing of RNA molecule (Fig. 1). Also trans-splicing has re-
cently been demonstrated to occur regularly in normal human cells
[7]. Trans-splicing involves two separate RNA molecules even from
genes locating on different chromosomes, whereas cis-splicing is a
result of a fusion of two neighboring genes as a single, united mes-
senger RNA molecule.
One challenge has affected genome assemblies until recently
and is still present in secondary databases: dozens of transcript
extension genes have traditionally been named in what could be
considered illicit unition in a gene matrimony, in e.g. the Ensembl
Gene IDs. We question whether the putative existence and occa-ll rights reserved.
la).sional usage of common or de novo ‘‘molten” exons really justiﬁes
assigning the longest transcript ID as the actual gene. Separation of
united genes would increase the information content of the gen-
ome contig annotation and prevent researchers from futile data-
mining. At the moment, use of transcript-driven accessions in the
query, for instance, in the Uniprot database [8], the most compre-
hensive catalog of information on proteins, may generate incorrect
results. This presents a systematic caveat in interpreting e.g. micro-
array meta-analysis results.
Ensembl is the authoritative software system that allows for
automatic analysis and annotation of contemporary genome se-
quence assemblies and visualization of the annotated genomes
[9]. Until recently, some entries have resulted in the production
of confounding family members due to intersplicing artifacts. Valu-
able sets of gene clusters with inconsistent topology have been col-
lected along the Ensembl project of various genome assemblies. A
new strategy has addressed this dilemma, such that transcript pre-
dictions are only clustered into genes when their coding sequences
overlap on the genome, in contrast to only overlapping on the tran-
script level (personal communication, Ensembl project). The artiﬁ-
cial, yet ofﬁcial in terms of nomenclature, merged genes of the
past, however, shed light on the putative pathology and etiology
of clinical transcriptomics.
The number of genes exhibiting occasional intergenic splicing
into a single, ‘‘tandem” RNA sequence with the potential of encod-
ing a chimerical protein sequence has been estimated to account
Fig. 1. Schematic representation of cis-splicing leading to chimeric gene fusions. Intergenic splicing combines exons from the upstream and downstream genes to form a
chimeric gene fusion. Occasionally, the intergenic region is preserved in the mRNA transcript, too.
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according to the ‘‘Encyclopedia of DNA elements” pilot project,
whose aim was to identify all functional elements in the human
genome, based on 1% of the human genome [10]. Although the de-
tailed gene cohorts reported [1–4] have not always been experi-
mentally veriﬁed, it is not surprising that these are only loosely
overlapping and rather non-redundant.
Whether the fused proteins with chimerical domains reﬂect a
dysregulation of the transcription termination by RNA polymerase
or serve a genuine teleonomic purpose remains an open question.
Is this phenomenon a functional one, or does it constitute a novel
pathological mechanism?
2. Methods
2.1. Gene symbols
We examined interspliced chimeras from 60 genes constitut-
ing 30 gene pairs from the 421 individual RefSeq transcript IDs
veriﬁed from tissues by Akiva et al. [1] as intergenic splice iso-
forms, and 106 genes constituting 53 gene pairs from the 352
RefSeq IDs listed by Parra et al. [2] as tandem pairs with ESTs
linking two transcripts. Since only 11 of the ‘‘molten” gene pairs
were in both major reports, the total number of the controversial
genes was 145. Twenty gene pairs of the 30 transcript fusion
pairs forced under a single Ensembl gene ID from Akiva et al.
and 30 gene pairs of the 53 fusion pairs from Parra et al. exhib-
ited both unconventional topology and multiple symbols. The
reference information for the 421+352 human genome gene fu-
sions was derived using Clone Gene ID-converter [11] and SRS
7 [12].
2.2. Randomizations of the enrichment and depletion analyses
Signiﬁcance of the scoring and prioritization of networks and
pathways according to the relevance to the chimeric gene sets
was evaluated based on the size of the intersection between input
data set and set of genes/proteins corresponding to the network
module in question. The setup can be considered as a sampling
without replacement and the probability to randomly obtain inter-
section of certain size between the input set, following hypergeo-
metric distribution. This means a null-hypothesis, whereby the
genes are regarded as independent with each others in terms of
annotation. Noteworthy, the manually curated MetaCore-Meta-
DrugTM platform takes into account also nodes representing litera-
ture entities without vis-a-vis gene correspondence, such as
protein complexes. The probability of a subset of size n to include
r marked ones provided that n and R are unrelated follows the
hypergeometric distributionPðr; n;R;NÞ ¼ C
r
RC
nr
NR
CnN
¼ C
r
nC
Rr
Nn
CRN
¼ R!ðN  RÞ!
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The mean of this distribution is equal to:
l ¼
Xn
r¼0
rPðr;n;R;NÞ ¼ nR
N
¼ nq
where q deﬁnes the proportion of the network or pathway in the
whole genome/dataset. The dispersion/variance of this distribution
is described as:
r2 ¼
Xn
r¼0
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These equations are invariant in terms of exchange of n for R
which means that the ‘‘subset” and ‘‘marked” are equivalent and
symmetrical sets. In the cases of
r > n; r > R or r < Rþ n N; Pðr;n;R;NÞ ¼ 0
the z-score is used for comparison and prioritization of the net-
works in the MetaCoreTM
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where l and r are the mean and standard deviation of the hyper-
geometric distribution. z-Score represents a measure of relative
deviation of r from its expected mean value. For the evaluation of
statistical signiﬁcance, the null-hypothesis which states that the
subsets R and n are independent and, therefore, the size of their
intersection follows the hypergeometric distribution, is considered.
The alternative hypothesis states that there is positive correlation
between the subsets. Based on these assumptions, p-value is calcu-
lated as the probability that intersection of two randomly selected
subsets of N would have the size of n or larger:
pValðr;n;R;NÞ ¼
Xminðn;RÞ
i¼maxðr;RþnNÞ
Pði;n;R;NÞ ¼ R!n!ðN  RÞ!ðN  nÞ!
N!

Xminðn;RÞ
i¼maxðr;RþnNÞ
1
i!ðR iÞ!ðn iÞ!ðN  R nþ iÞ!
In short, the randomization is carried out beforehand in the
GeneGo MetaCoreTM platform and taken into account in the output
p-values.
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the enrichment method of the GeneGo MetaCoreTM as end-users
who do not have the full access to its MetaBase (i.e. local down-
loading of the databases found in the knowledgebase). More spe-
ciﬁcally, we performed an independent evaluation of the
aforementioned null-hypothesis assumption, by carrying out ran-
domization of corresponding input accession codes against the
public Gene Ontology (GO) classes that are also found in the Gene-
Go MetaCore platform aside its proprietary systems medicine and
toxicology annotation databases. In this evaluation, we compare
randomization-derived empirical p-values with the p-values re-
ported by GeneGo platform against the public GO. In the cases of
the putatively ﬂawed nomenclature possibly inﬁltrating the
Ensembl platform with identical gene accessions for both the up
and downstream fusion genes, these gene pairs were considered
as one input item when calculating the size of the input gene sets.
Classes were obtained by using the Ensembl gene IDs and
obtaining the classiﬁcations from ID-Converter web tool [11]. Ob-
tained GO mappings were used to link genes to reported and
parental GO classes. Only classes that had more than three genes
were included to the dataset. Analysis of GO classes was done
using the one-sided hypergeometric test, designed to monitor both
over- and under-representation [13] We omitted the genes that
were not mapped to GO, according to a procedure veriﬁed before
[14] as for these genes there is no clear information whether they
belong or do not belong to the classes. Some classes showed strong
signal in empirical p-value analysis, with all the results from the
randomization showing weaker signal. This generates the p-va-
lue = 0, and as the results were analyzed as 10 based logs, these
cases were un-calculatable. Therefore these cases were modiﬁed
by adding 0.5 to number of better observations. The generated
GO data included 6090 classes. This generates a signiﬁcant Multi-
ple Testing problem, generating seemingly signiﬁcant results. We
performed, therefore, an analysis of 500 random gene lists for each
analyzed gene sets with exactly identical size and identical GO data
matrix. The randomizations allow us the generation of empirical p-
values for each rank in the sorted list of positive results, by using
the ordered results from each randomization with the same rank
as a reference. A similar idea has been used for example in the
analysis of the hierarchical trees with GO classes [15]. The draw-
back of this method is that as the reference p-values for the lower
ranks in the sorted GO class list are naturally weaker, one can actu-
ally get better empirical p-values for the lower ranks in the GO
class list. In addition, the method does not account for the correla-
tion occurring between the GO classes. Therefore, we added an
over-conservative empirical p-value analysis to the procedure, where
each rank of p-values is compared to the best result from each ran-
domization. This is otherwise similar to the method represented in
[15] but with the more stringent criterion that our novel method
maintains the same, hardest reference pool for all the ranks. The
methods produce the same result for the ﬁrst class in the ordered
GO class list, but in the descending ranking, the over-conservative
method starts to penalize the obtained results with an extra cost.
Our method reports not only enrichment, but also depletion or
deprivation signals, in contrast to the GeneGo MetaCoreTM. These
are relevant, however, for the annotation classes containing many
gene members. We consider that these two represented empirical
p-values give a reliable estimate on the actual probability on seeing
similar or stronger results by random. We are not aware of more
stringent methods for the analysis of true signiﬁcance of the class
enrichment or depletion methods.
2.3. Text mining
Quantitative text mining analysis of the published interacting
partners of the chimera constituents was derived by AriadneGenomics Pathway Studio Enterprise 5.0 based on ResNet 5.0
Knowledgebase and MedScan natural language processing against
PubMed abstracts (Ariadne Genomics Inc., Rockville, USA) [16]. The
common and unique attributes and property enrichment of the
genes undergoing intergenic splicing were also compared against
the GeneGo Inc’s MetaCore-MetaDrug platform, the putatively
widest, human-speciﬁc, manually curated systems medicine data-
base available [17]. This systems biology knowledgebase only
takes into account causal relations (in contrast to unveriﬁed
high-throughput screening associations).
2.4. Ensembl discrepancy analysis
In the Ensembl project discrepancy analysis from Supplemen-
tary Table S2 S2, the multiple category criterion refers to tran-
scripts of a particular gene associated with more than one gene
symbol associated with RefSeq or Swiss-Prot records for the same
species. In regard to the topology criterion, a gene has at least three
transcripts and one transcript ends before another one starts,
which would be the case if there was a longer transcript that would
join two genes into one cluster. In the clustering criterion, overlap-
ping of the exon start or end coordinates was detected. In the
topology criterion, two transcripts have been clustered into the
same Ensembl gene based on genomic overlap, and the script be-
hind provides a more stringent search for overlapping exon bound-
aries. In the case when there is no overlap, the script indicates sub
clusters where it ﬁnds matching exon coordinates. Splice variants
are assumed to have at least one exon overlap, according to con-
ventional deﬁnition, but this appears to not always be observed
in empirical biology. The problematic contigs were originally de-
rived from the Ensembl assembly 43, and the script used to classify
the genes is described in Supplementary Table S2. At the contem-
porary most recent assembly release 50, the Ensembl deposit is no
longer maintained and thus can not be used as a source of informa-
tion on the transcript level fusions and other discrepancies.3. Results
3.1. Enrichment of the transcript fusions in gene ontologies and disease
annotations
Akiva et al. [1] reported 213 gene pairs and Parra et al. (2006)
[2] 176 gene pairs that exhibited intergenic splicing, whereas the
Ensembl project listed 709 genes with multiple symbols, 460 genes
with inconsistent cluster topology, 264 problematic genes based
on clustering, and 217 genes with discrepant gene names (Supple-
mentary Table S2). Only 105 individual genes were common to
both Akiva et al. and Parra et al. which contained 268 and 198 un-
ique genes, respectively (Supplementary Fig. S1). Therefore, we
analyzed their common and unique attributes and report their
property enrichment to the putatively widest, manually curated,
human-speciﬁc relation database available [17], and compared
all 1760 most controversial genes from the Akiva et al. (2006)
and Parra et al. (2006) reports, as well as Ensembl deposit against
GeneGo’s MetaCore-MetaDrug platform. In the GeneGo platform,
349 gene IDs had been annotated to canonical maps, 593 in dis-
eases, 742 in public gene ontology, and 1197 in networks.
In the manually validated GeneGo MetaCore-MetaDrugTM
systems medicine platform, the controversial gene sets or their
combinations were most signiﬁcantly associated with the neuro-
logical Cockayne syndrome, pregnancy complications, genital dis-
orders, epilepsies, thalassemia, alcohol-induced neurological
delirium and neuroectodermal tumours. Notably, four essential
genes out of the 28 annotated to thalassemia were included among
the transcript fusions: hemoglobin alpha-1, hemoglobin gamma-1,
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toxicological networks enriched were nucleotide-excision repair
in DNA damage, antigen presentation, various circuits of the cell
cycle, and transmission of nerve impulses.
In terms of functions, the most enriched molecular processes in
the systems biology section (in contrast to the systems medicine)
of the MetaCore-MetaDrugTM were related to cytoskeletal dynam-
ics, meiotic cell division, transcription, folding and neurohormone
signalling. More speciﬁcally, the gene set behind Parra et al. (2006)
included components of both intermediate ﬁlament and tubulin
networks affecting cell division. The common and unique genes
among the gene sets attributed to intergenic splicing or other
inconsistent RNA topologies described above are displayed in Sup-
plementary Fig. S1. The most enriched gene ontologies in GeneGo
processes are displayed in Supplementary Fig. S2, disease biomark-
ers in Supplementary Fig. S3, and GeneGo toxicity classes in Sup-
plementary Fig. S4, taking into account all gene sets except the
most divergent Ensembl deposit of disagreeing gene symbols.
Next, we investigated the nature of the fragmentary reports of
the transcript fusions and Ensembl depots for controversial gene
contigs one by one to gain insight into the actual molecular biology
behind the phenomena. In order to compare the enrichment meth-
od of the commercial GeneGo MetaCore-MetaDrugTM platform to
the analogous results subtracted with randomization, we utilized
projection against the public Gene Ontology (GO). Upon a local
downloading of the current human genome (Ensembl assembly
50) and the respective 141,631 GO annotations of the 36,396 puta-
tive human gene ID’s, not only enrichment analysis but also impov-
erishment (depletion) analysis was carried out. This was done with
the same hypergeometric distribution method as inside the Gene-
Go, but with with extensive external extra randomization round
afterwards with artiﬁcial input gene sets, to substract and derive
empirical p-values against the background noise. Here, the com-
mon genes inside the controversial gene sets were not combined
with optimal permutations, which is feasible only in the Meta-
CoreTM, but the gene sets were individually scrutinized.
As a result, the GO projection from the GeneGo platform
brought forth similar enrichment results than our inhouse enrich-
ment with randomizations. Supplementary Fig. S5 shows the
GeneGo enrichment to GO Biological Processes, Supplementary
Fig. S6 shows the GeneGo enrichment to GO Molecular Functions,
and Supplementary Fig. S7 shows the GeneGo enrichment to Cell-
ulac Components. In comparison, Supplementary Table S1 shows
our inhouse enrichment results and depletion results (marked as
‘‘2way” method). Since the number of randomizations was 500,
the maximal enrichment in terms of empirical p-values could be
only <0.001 or E-3 (marked as >3, in the log scale), although the ob-
served p-values reached as low levels as E-10.
In the GO Biological Processes, the Ensembl controversies
with clustering criterion and multiple symbols were signiﬁcantly
enriched in the classes of nucleosome assembly, chromatin
assembly, and DNA packaging; the category of discrepant sym-
bols in antigen presentation; the category of topology criterion
in regulation of small GTPases, and the gene set behind Parra
et al. (2006) only slightly in protein polymerization. In the GO
Molecular Functions, the category of topology criterion was en-
riched in GTPase regulation; the category of discrepant symbols
in MHC II receptor activity and tapasin binding; and the category
of clustering criterion in DNA binding. In the GO Cellular Compo-
nents, the Ensembl controversies with clustering criterion and
multiple symbols were enriched in the classes of protein-DNA
complex, nucleosome and chromatin; and the the category of
topology criterion in M-band.
Our inhouse method for deprivation detected also depletion of
metabolic regulation in the gene set of the clustering criterion.
The most important enrichments that the MetaCoreTM underesti-mated in comparison to our randomization method were positive
regulation of cytokine secretion (clustering criterion), and the
enrichment of the genuine intergenic transcript fusions behind
Akiva et al. (2006) and Parra et al. (2006) as a merged gene set
to mitochondrion and oxidoreductive activity.
The most established, mutual binding interaction network at
the protein level for the intergenic splicing transcripts included
in both Akiva et al. (2006) [1] and Parra et al. (2006) [2] is dis-
played in Fig. 2. The most remarkable cluster around the BMI-1
stem cell regulator are inhibitions of transcription, and the most
enriched relations include also the blood clotting cluster, which
are typically proteolytic cleavages. The GRB2 adaptor network
was the most important hub in the physical interactome, con-
nected, for example, to cytoskeletal and histone-regulating
proteins.
Next, all ﬁve controversial gene sets were studied as a whole,
including also the more divergent Ensembl deposit of disagreeing
gene symbols and objects unique to only one gene set. The most
statistically signiﬁcant hubs controlling other genes with contro-
versial borders were the transcription factors (causal edges; total
number/upstream incoming edges): HNF4-alpha (170/8), E2F1
(13/2), HIF1A (10/0), SMAD4 (8/0), TCF4 (7/0), RUNX2 (6/2),
HNF3-beta (5/2), LRH1 (5/0), ESR2 (4/0), CREM regulators, and
members of the HOXA family. The most central receptor by far
was the proto-oncogene tyrosine–protein kinase receptor RET (5/
0), which is relevant to enteric nervous system maturation and
neural crest cell migration. The most central secreted peptides
were interferon-alpha (3/3), carcinoembryonic antigen-related cell
adhesion molecule 1 (CEACAM1; 3/0) and WNT isoforms. Other
protein hubs were histone 2B (10/9), histone 2A (8/8), Cdc42 (9/
0), kallikrein 3 (PSA; 8/5), GRB2 (8/0), and BMI-1 (8/0). The cardinal
divergence hub among these vulnerable genes was the transcrip-
tion factor hepatocyte nuclear factor 4-alphaHNF4A, which regu-
lates blood coagulation and lipid metabolism through
transcription from RNA polymerase II promoter. The most enriched
processes against the interactome around the HNF4A network
were chromatin assembly (p = 1.901e05), nucleosome assembly
(p = 1.948e05), and digestion (p = 1.065e04). The main conver-
gence hub was UDP-glucuronosyltransferase UGT, which is signif-
icant in hemi, bilirubin, retinol and steroid metabolism and
response to toxins.
In their endeavor to predict human genes not yet in the gene
catalogs in silico using methods that do not require cDNA, Siepel
et al. (2007) [4] identiﬁed 734 ‘‘novel gene fragments” (NGFs) with
at least one novel exon, containing altogether 2188 exons. Out of
these, 563 were distinct genes, 327 were completely novel clusters,
160 were previously unknown proteins, and hundreds of the rest
were analogous signiﬁcant extensions of transcription induced chi-
meras. These NGFs seemed to be expressed at low levels and in a
tissue-speciﬁc manner, but their comparison to the other gene sets
is not straightforward, as they were reported as novel accession
codes and not in regard to conventional gene symbols and bound-
aries. In addition, a large proportion of the genomic coordinates of
these NGF clusters did not have extensive (or any) overlap with
known genes. They were enriched in annotations of motor activity,
cell adhesion, connective tissue, and central nervous system
development.
3.2. Standardization of the open reading frames
Since standard ORF (open reading frame) is essential to genes
by deﬁnition, the existence of these untypical and unannotated
exons in low abundance (in addition to the fused introns) is an
indication towards the pathological nature of transcript fusion.
We therefore examined whether any of the peculiar gene catego-
ries reported recently in the exhaustive open reading frame con-
Fig. 2. Mutual interaction network for the putative intergenic splicing transcripts included in the pioneering discoveries by Akiva et al. [1] and Parra et al. [2]. If the
observation reveals a novel pathological mechanism, these putative protein complexes are most likely to be affected. In particular, the housekeeping or homeotic HOX-
transfactors centered around BMI-1 warrant further attention in developmental biology. Only the direct interactions are displayed. Blue arrows indicate activation and red
arrows inhibition. As deﬁned by the GeneGo Inc MetaCore/MetaDrug systems medicine platform, the symbols are as follows: enzyme; kinase; protease; protein;
generic binding protein; transfactor; GTPase; G-protein adaptor; receptor; receptor ligand; transporter; GPCR; channel.
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overlapped with the ﬁrst fragmentary gene sets of the fused pro-
teins. The RCF database divides human genes into the main catego-
ries of ortholog, cross species paralog, human-speciﬁc paralog,
functional pseudogene, functional transposon, pfam structural
family supported, special regions, redundant, pseudogene, transpo-
son, artifact, and 1177 orphan genes (Ensembl 35) that do not
share RFC even with primates and display less amino acid se-
quence identity to other mammals. Assuming that RFC and its loss
as such reﬂect functionality and dysfunction, respectively, Clamp
et al. predicted, indeed, that the 1177 human Ensembl genes are
not real genes. Out of 22,219 human genes, a total of 14,257 genes
displayed 100% RFC with dog (88.5% AA id) and 14,157 genes 100%
RFC with mouse (85.2% AA id). In Supplementary Fig. S8, we show
that when RFC drops below 100%, the amino acid identity also dra-
matically drops down when qualitatively ascending from 100%
RFC. Alternative splicing, in general, seems to be less conserved
than the amino acid sequence identity if a mammal is compared
to a representative of other phyla, since splicing is more rare in
simpler organisms [19]. In human, only about 6% of human genes
are made from a single, linear piece of exon and the maintenance
of genetic border regions seems to be important also in general
in the light of comparative genomics.
3.3. Inconsistent termination of the polymerase reaction
Akiva et al. [1] observed that there was an intergenic distance
bias in fused compared with nonfused genes in favor of shortintergenic regions. In regard to the RNA polymerase, transcript
fusion could be likened to a train that fails to stop at a station
with too short a platform. Denoeud et al. [3] reported what they
called RACEfrags, tissue- or cell-line-speciﬁc transcribed frag-
ments 50 distal to the annotated 50 terminus, which fused the
open reading frames (ORFs) of the adjacent transcripts in 20%
of the cases. The authors used 50 rapid ampliﬁcation of cDNA
ends (RACE) that allows detection of low-copy-number tran-
scripts/isoforms to argue that at least at this low abundance le-
vel, intergenic splicing is much greater than previously
anticipated. However, only 132 genes including many synonym
names in the conventional gene conventions were cloned in
the study, so the cohort does not contribute much to parallel
gene set enrichment analysis.
As for the phylogenetic occurrence, genes of similar function
tend not only to be maintained in close proximity but also tend
to be present or absent together. In comparative genomics, gen-
uine gene fusions are seen for subunits of protein complexes en-
coded by separate genes in other organisms, which for example
is the foundation for the String database [20]. We emphasize
that the transcript fusion phenomenon described above is in
nearly all cases in altogether different category and not deduced
from, or supported by, these functional tasks typically related to
substrate channelling in metabolism seen in comparative
genomics. Besides, Denoued et al. [3] reported that the analyzed
novel exons were relatively poorly conserved as a whole across
species, although some conservation of novel internal exons in
mammals was noticed.
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In the emerging era of transcriptomics meta-analysis, the clus-
ter based approach of the Ensembl nomenclature is indispensable
in terms of gene coverage when comparing genome-wide expres-
sion correlation lists. Based on the hypothesis of epigenetic histone
code working on predestined expression programs, the short
mRNA phase is an ideal time window to assess the biological role
of a gene, instead of its concentration in the effectors’ protein level.
Transcript fusion, sharing of the same DNA sequence in a different
reading frame, extensive antisense transcription, ligation of two
separate mRNAmolecules (trans-splicing), thousands of noncoding
RNAs, as well as alternative splicing and alternative promoters,
however, confound this approach [21].
The HGNC and Swissprot symbols of the transcription induced
chimeras misinterpreted as mere splice isoforms of the same gene
are fatal, but unfortunately do exist, as summarized in Supplemen-
tary Table S2. The usage of overlapping Gene IDs (the ENSG. . .-con-
vention) in these sixty transcripts (the ENST. . .-convention) has led
to autological classiﬁcation of the extended ‘‘genes” as Ensembl
family members (the ENSF. . .-convention) in many cases. In the
protein family category, the claim has been more easily further
propagated. The annotations, as indicated by the link to the Uni-
prot database, can refer to either up or downstream transcripts.
It is, indeed, difﬁcult to track down how the error has been propa-
gated further in the databases and converter servers.
Reassignments lead to displacements of misleading gene IDs to
new and exclusive codes. Since the pioneering chimera reports, all
145 fused human gene accessions or 72 pairs challenged here were
still in use in the Ensembl release 43 (February 28th 2007), as
shown in Supplementary Table S2. Fortunately, Ensembl regularly
associates more than one gene symbols to clusters as a link to indi-
cate that more than one biological gene may have been subsumed
in a particular cluster. Also, corresponding GeneView pages, the
manual Ensembl Vega project, as well as the Ensembl data-mining
tool BioMart contain more speciﬁc information for genes for a ca-
sual end-user. The Ensembl project responded to ﬁnally tackle the
problem with a new strategy in release 47 (23rd October 2007)
that contained a full re-build of the human gene set. In this re-
build, the clustering strategy was also altered so that transcript
predictions are only clustered into genes when their coding se-
quences overlap in the genome, in contrast to only overlapping
on the transcript level. This change in strategy improved the situ-
ation, although in the current release 50, at least 82 genes or 41 of
the transcript pairs identiﬁed in either Akiva et al. [1] or Parra et al.
[2] are still merged under same gene ID.4. Discussion
Although over 60% of the bulk DNA in mammalian genomes ap-
pears to be transcribed [5], the mRNA half-life is the least under-
stood stage in the way too simplistic idiom of the central dogma
(‘‘DNA makes RNA makes protein”). In a corresponding manner
to human SNP polymorphism and copy number variation (CNV),
sequencing efforts of ESTs and full-length cDNA are only beginning
to be extensive enough to quantitatively comprehend transcripto-
mics. Do the extended fusion transcripts, then, bear a functional
signiﬁcance, or do they just accidentally appear upon RNA process-
ing? Do they merely contribute to variation, or is transcript fusion
a novel pathological mechanism?
The drop in sequence identity in comparative genomics along
with the drop of the conservation of open reading frame (Fig. 3)
indicates that the borders of the genes are critically error-prone.
Are some RNA polymerase isoforms more prone to miss termina-
tion? It is fascinating that there are three codons that stop peptidesynthesis, since some of the transcript fusions are also seen at the
protein level. Based on this ‘‘splicing wobble”, especially at pro-
moter and terminator regions, we suggest that untypical splicing
patterns in general, transcript extensions in particular, constitute
a novel disease mechanism. The pioneering ﬁndings of intergenic
splicing have been discussed in the context of a surprising but
functional level of gene regulation. The ability of these genes to un-
dergo gene fusion does not seem to be omnipresent across neither
the population nor the human body, and seems to be more or less
random. Intergenic splicing has been discussed in the context of
deriving protein diversity for functional variation that brings selec-
tion beneﬁts after reverse transcription and retrotransposition in
the genome [1,3], in the same vein as the role of alternative splic-
ing is emphasized in the mammalian genome. In contrast, dysreg-
ulation of the transcription termination with pathological outcome
has rarely been even proposed. Ruan et al. [22], however, have de-
tected such transcribed retrotransposed loci in cancer genomics. In
addition, Kim et al. [23] introduced a server based on a database of
2344 hybrid gene pairs in the human genome, including intergenic
splicing as well as trans-splicing and sense/antisense transcription,
and emphasized the role of the truncated proteins as candidate risk
factors [24].
When the annotations of gene set associated with open chro-
matin regions were compared to the veriﬁed chimeras against
the public Gene Ontology (GO) [3], Denoeud et al. did not ﬁnd
any obvious association. Unfortunately, the public annotation dat-
abases such as GO do not contain hierarchic or indexed clinical
designations for genes. Here, by using the GeneGo Inc’s Meta-
Core/MetaDrug systems medicine platform whose annotation class
members are more interwoven in the literature as gene circuits or
constituents of the same protein complexes, we show that such
enrichments do exist in the disease hierarchy. Extended by the
ﬁndings of the inconsistent or unconventional gene topologies at
the Ensembl genome assembly project and by the various unlikely
gene entities reported by the Eric Lander group [18], these gene
sets are only loosely overlapping and non-redundant. In the level
of annotation, we noticed that the chimeras are, nevertheless, en-
riched to some biomedical classes. Intergenic splicing seems to
be important especially in the etiology of neurological disorders,
thalassemia and pregnancy or genital disorders. The statistically
most signiﬁcant processes exposed to the phenomenon of inter-
genic splicing were related to cytoskeletal dynamics regulating cell
division. The statistically most signiﬁcant indication of teleonomic
function in the molecular biology was not derived from the genu-
ine intergenic splicing but from the Ensembl controversy catego-
ries of clustering criterion and multiple symbols, both of which
were related to chromatin remodelling and histone organization.
The gene sets with inconsistent topology were enriched in the clas-
ses of GTPase regulation. Discrepant symbols are most often
encountered in the disciplines of MHC complex and antigen pre-
sentation and processing. Regarding the randomization results as
such, the GeneGo method following Hypergeometric distribution
performed as a reliable method for gene set enrichment analysis
without intensity values or ranking position attached to genes.
Interestingly, the alternative splicing program has been shown
to differ particularly in the nervous system tissues compared to
other mammalian tissues [25]. Pathways that detect and selec-
tively eliminate defective messenger RNAs are known as surveil-
lance pathways and operate either in a more general way in
many cell types or speciﬁcally in only certain cell types. Several
surveillance pathways have been identiﬁed that recognize speciﬁc
types of mutations in RNA. For instance, one pathway recognizes
nonsense mutations that result in an RNA that results in a trun-
cated protein. Duchenne’s muscular dystrophy and cystic ﬁbrosis
are examples of hereditary diseases that result from nonsense
mutations. A recent and notorious ﬁnding regards the red blood
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mon genetic form of anemia worldwide [26]. Noteworthy, hemo-
globin alpha-1, hemoglobin gamma-1, hemoglobin gamma-2, and
glucose-6-phosphate isomerase that exhibit transcript fusion are
among the vulnerable agents that expose a patient to thalassemia.
Final proof for RNA polymerase dysregulation mediated diseases
would be to quantitate the RNA aggregates from pathological or-
gans. Denoued et al. also noted the importance of speciﬁc organs,
especially testis, stomach, kidney and brain, as the stage for the fu-
sion. When the tissue speciﬁcity of the pioneering datasets by Aki-
va et al. [1] and Parra et al. [2] were studied here in the Applied
Biosystems based GeneGo platform covering 31 human tissue
types, no evident correlation was seen in the tissues.
The Ensembl project has ﬁnally reacted and tackled previous
challenges with a new strategy so that transcript predictions are
only clustered into genes when their coding sequences overlap
on the genome, in contrast to just overlapping on the transcript le-
vel. This change in strategy has improved the situation consider-
ably, and other databases should react to the dilemma that has
led to systematic misinterpretation of HTS data. Likely, the situa-
tion is much worse in organisms other than humans. The complete
gene catalog even for humans is a moving target since the classic
deﬁnitions of gene are on trial. Nevertheless, it is critically impor-
tant that the broad coverage reference system is still developed to
better serve the community. This becomes ever more important if
transcript chimerism contributes to pathologies, particularly in the
versatile splicing program of the nervous system.
In short, instead of teleonomic molecular function, the data
indicates that intergenic splicing might stochastically cause
pathologies, for which we suggest certain hotspots. We argue that
transcript chimeras might constitute an underestimated patholog-
ical mechanism akin to the copy number variation due to ribosome
crowding and loss of stoichiometric ratios in the subunits of com-
plexes by the law of mass action. The emerging era of clinical
transcriptomics would be good news since new disease etiologies
offer new remedies. Whether the hotspot networks affected by
interspliced chimeras such as the developmental, housekeeping
or homeotic HOX-transfactors centered around BMI-1, the adaptor
network centered around Grb2, the Hif1A-kallikrein system, or the
hemoglobin network identiﬁed here could be targeted by interfer-
ing strand microRNAs in the future warrants further research.
RNA-based therapy is a new avenue for biomedicine, in the advent
of drugs based on RNA interference for both coding and noncoding
strands. A prerequisite for the advancing RNA interference thera-
peutic treatment after identiﬁcation of pathological splicing chi-
mera hotspots is the individual veriﬁcation of the chimera with
corresponding symptoms in the tissue in a patient compared to a
healthy control tissue with the absence of symptoms and chime-
rism from the same individual. The phenomenon is also a new
parameter in the organ and stem cell transplantations and de novo
molten exons are likely to be detected immunologically to cause
havoc.5. Conclusion
In this study, we (i) postulate that the fused transcript chimeras
constitute a novel and neglected pathological mechanism affecting
especially chromatin remodelling and cytoskeleton, instead of a
teleonomical function; (ii) identify hotspot networks affected by
intergenic splicing comprising homeotic HOX-transfactors cen-
tered around BMI-1, Grb2 adaptor network, kallikrein system,
and thalassemia RNA surveillance; and (iii) argue against a system-
atic error in the chimerical gene accession nomenclature. The latter
has led transcriptomics meta-analysis of HTS arrays astray in the
case of at least 145 human genes, some of which are extremely ac-tively studied, and much more in other organisms. Finally, we (iv)
argue that the emerging era of clinical transcriptomics is of signif-
icant beneﬁt, as new disease etiologies also offer new remedies.
That is to say, the advancing RNA interference technology may pro-
vide a cure after the pathological splicing chimera hotspots have
been individually veriﬁed in a patient with corresponding symp-
toms in the tissue with affected chimerism, compared to healthy
control tissue with the absence of symptoms and chimerism from
the same individual. Our proposal as a solution for the current gene
annotation dilemma is (i) Not to use transcript stage as a basis for
gene nomenclature at all. (ii) To insert caution remarks for the gene
entries which are still named on the basis of intergenic chimeras
seen in the transcript stage. We recommend, however, that the
genome browsers such as Ensembl continue the maintenance of
the depot of the controversial gene contigs, since these exceptional
and occasional ﬁndings may be, indeed, pathologically informative.
At the moment, such an entry has been discontinued.Acknowledgments
We are grateful to the EBI Ensembl project personnel for quick
and cordial technical support and speciﬁcally acknowledge Mi-
chael Schuster for compiling lists of human genes with controver-
sial architecture. We also acknowledge CSC Center for Science Ltd,
administered by the Ministry of Education in Finland, for providing
supercomputer facilities for systems biology we feel gratitude to-
wards Mikko Frilander for ex cathedra deﬁnitions of splicing sub-
types. We want to thank the Academy of Finland for funding.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.jbi.2008.11.002.
References
[1] Akiva P, Toporik A, Edelheit S, Peretz Y, Diber A, Shemesh R, et al.
Transcription-mediated gene fusion in the human genome. Genome Res
2006;16:30–6.
[2] Parra G, Reymond A, Dabbouseh N, Dermitzakis ET, Castelo R, Thomson TM,
et al. Tandem chimerism as a means to increase protein complexity in the
human genome. Genome Res 2006;16:37–44.
[3] Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, Drenkow J, et al.
Prominent use of distal 5’ transcription start sites and discovery of a large
number of additional exons in ENCODE regions. Genome Res 2007;17:746–59.
[4] Siepel A, Diekhans M, Brejová B, Langton L, Stevens M, Comstock CL, et al.
Targeted discovery of novel human exons by comparative genomics. Genome
Res 2007;17:1763–73.
[5] Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, et al. The
transcriptional landscape of the mammalian genome. Science
2005;309:1559–63.
[6] Kapranov P, Cawley SE, Drenkow J, Bekiranov S, Strausberg RL, Fodor SP, et al.
Large-scale transcriptional activity in chromosomes 21 and 22. Science
2002;296:916–9.
[7] Li H, Wang J, Mor G, Sklar J. A neoplastic gene fusion mimics trans-splicing of
RNAs in normal human cells. Science 2008;321:1357–61.
[8] Uniprot database. Available from: http://www.ebi.uniprot.org.
[9] Hubbard TJ, Aken BL, Beal K, Ballester B, Caccamo M, Chen Y, et al. Ensembl
2007. Nucleic Acids Res 2007; 35:D610–617. Ensembl database is Available
from: http://www.ensembl.org.
[10] ENCODE Project Consortium. The ENCODE (ENCyclopedia Of DNA Elements)
Project. Science 2004; 306: 636–40.
[11] Alibés A, Yankilevich P, Cañada A, Díaz-Uriarte R. IDconverter and IDClight:
Conversion and annotation of gene and protein IDs. BMC Bioinformatics 2007;
8:9 link. ID-converter. Available from: http://idconverter.bioinfo.cnio.es/.
[12] Etzold T, Ulyanov A, Argos P. SRS: information retrieval system for molecular
biology data banks. Methods Enzymol 1996; 266:114–28. Sequence Retrieval
System. Available from: http://srs.im.ac.cn/.
[13] Toronen P. Selection of informative clusters from hierarchical cluster tree with
gene classes. BMC Bioinformatics 2004;5:32.
[14] Kankainen M, Brader G, Törönen P, Palva ET, Holm L. Identifying functional
gene sets from hierarchically clustered expression data: map of abiotic
stress regulated genes in Arabidopsis thaliana. Nucleic Acids Res
2006;34:e124.
M. Tolvanen et al. / Journal of Biomedical Informatics 42 (2009) 382–389 389[15] Marco A, Marín I. A general strategy to determine the congruence between a
hierarchical and a non-hierarchical classiﬁcation. BMC Bioinformatics
2007;8:442.
[16] Novichkova S, Egorov S, Daraselia N. MedScan, a natural language processing
engine for MEDLINE abstracts. Bioinformatics 2003;19:1699–706.
[17] Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of
signature networks as biomarkers from complex high throughput data. Toxicol
Lett 2005; 158:20-9. MetaCore-MetaDrug database. Available from:
www.genego.com.
[18] Clamp M, Fry B, Kamal M, Xie X, Cuff J, Lin MF, et al. Distinguishing protein-
coding and noncoding genes in the human genome. Proc Natl Acad Sci USA
2007;104:19428–33.
[19] Takeda J, Suzuki Y, Nakao M, Barrero RA, Koyanagi KO, Jin L, et al. Large-scale
identiﬁcation and characterization of alternative splicing variants of human
gene transcripts using 56, 419 completely sequenced and manually annotated
full-length cDNAs. Nucleic Acids Res 2006;34:3917–28.
[20] String database. Available from: http://dag.embl.de/newstring_cgi/
show_input_page.pl.[21] ENCODE Project Consortium. Identiﬁcation and analysis of functional elements
in 1% of the human genome by the ENCODE pilot project. Nature 2007;
447:799–816.
[22] Ruan Y, Ooi HS, Choo SW, Chiu KP, Zhao XD, Srinivasan KG, et al. Fusion
transcripts and transcribed retrotransposed loci discovered through
comprehensive transcriptome analysis using Paired-End diTags (PETs).
Genome Res 2007;17:828–38.
[23] Kim DS, Huh JW, Kim HS. HYBRIDdb: a database of hybrid genes in the human
genome. BMC Genomics 2007;8:128.
[24] Hybrid and chimera databases. Available from: http://www.primate.or.kr/
hybriddb/ and http://genome.ewha.ac.kr/ChimerDB/.
[25] Fagnani M, Barash Y, Ip JY, Misquitta C, Pan Q, Saltzman AL, et al. Functional
coordination of alternative splicing in the mammalian central nervous system.
Genome Biol 2007;8:R108.
[26] Kong J, Liebhaber SA. A cell type-restricted mRNA surveillance pathway
triggered by ribosome extension into the 3’ untranslated region. Nat Struct
Mol Biol 2007;14:670–6.
